The chief executive talks industry trends, challenges and what’s in store for PCI Pharma Services as it continues its rapid growth and global expansion strategy
Aesica is investing $4.7 million in a new high containment facility, significantly extending its current capabilities in the formulation and packaging of liquid and solid dosage forms.